SCHEMBL24444565

SCHEMBL24444565

COc1cc2c(Oc3ccc(N4CCN(Cc5ccccc5)CC4=O)c(C)c3)ccnc2cc1O

nearest known ligand 0.51

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MET P08581 12/20 0.46
KDR P35968 8/20 0.46
LCK P06239 6/20 0.46
TEK Q02763 4/20 0.43
SYK P43405 1/20 0.42
FGFR2 P21802 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL372087 0.82 MET (0.57) METKDRSYKFGFR2
SCHEMBL20525605 0.72 DRD2 (0.43) MET
SCHEMBL371832 0.71 ACHE (0.60) METKDRFGFR2
SCHEMBL2864532 0.70 MET (0.63) METKDRSYKFGFR2
SCHEMBL5824479 0.69 SIGMAR1 (0.63) METKDRLCKTEKFGFR2
SCHEMBL10701655 0.69 ADRA1B (0.53)
SCHEMBL2063576 0.69 FGFR2 (0.64) METKDRFGFR2
SCHEMBL2064072 0.68 PDGFRA (0.58) METKDRFGFR2
SCHEMBL17489704 0.68 PDGFRA (0.65) KDRFGFR2
SCHEMBL4141203 0.67 FGFR2 (0.60) KDRFGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3329918-B1 C-MET MODULATORS AND METHODS OF USE EXELIXIS INC (US) 2022-05-25 EP disclosed